$MDXG
MIMEDX GROUP, INC. Stock $mdxg

$mdxg Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000137633922000127 Filed on November 02, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$74.38M	$67.69M	$63.07M
YoY Change	10.33%	7.32%	-1.91%
Cost Of Revenue	$14.37M	$12.19M	$10.13M
YoY Change	33.63%	20.33%	-1.56%
Gross Profit	$60.01M	$55.50M	$52.95M
YoY Change	5.91%	4.83%	-1.98%
Gross Profit Margin	80.68%	81.99%	83.94%
Selling, General & Admin	$49.95M	$53.48M	$46.29M
YoY Change	-5.87%	15.52%	-3.66%
% of Gross Profit	83.24%	96.35%	87.43%
Research & Development	$5.400M	$5.953M	$4.368M
YoY Change	18.06%	36.29%	29.54%
% of Gross Profit	9.0%	10.73%	8.25%
Depreciation & Amortization	$978.0K	$831.0K	$923.0K
YoY Change	-14.66%	-9.97%	-41.06%
% of Gross Profit	1.63%	1.5%	1.74%
Operating Expenses	$55.53M	$59.43M	$50.66M
YoY Change	-3.95%	17.31%	-1.48%
Operating Profit	$4.473M	-$7.103M	-$1.075M
YoY Change	-485.94%	560.74%	-88.93%
Interest Expense	-$1.450M	-$1.270M	-$963.0K
YoY Change	23.51%	31.88%	-34.49%
% of Operating Profit	-32.42%
Other Income/Expense, Net	-$3.000K	$0.00	$0.00
YoY Change	-85.0%		-100.0%
Pretax Income	-$386.0K	-$8.373M	-$2.038M
YoY Change	-118.32%	310.84%	-89.48%
Income Tax	$28.00K	$53.00K	$301.0K
% Of Pretax Income
Net Earnings	-$2.110M	-$8.426M	-$2.339M
YoY Change	-195.26%	260.24%	-87.95%
Net Earnings / Revenue	-2.84%	-12.45%	-3.71%
Basic Earnings Per Share		-$0.09	-$0.04
Diluted Earnings Per Share	-$0.02	-$0.09	-$0.04
COMMON SHARES
Basic Shares Outstanding	113.7M shares	113.6M shares	110.7M shares
Diluted Shares Outstanding		113.4M shares	110.7M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$65.95M	$73.22M	$90.61M
YoY Change	-24.27%	-19.19%	-17.33%
Cash & Equivalents	$65.95M	$73.22M	$90.61M
Short-Term Investments
Other Short-Term Assets	$2.631M	$2.582M	$860.0K
YoY Change	-6.34%	200.23%	-84.28%
Inventory	$13.18M	$13.98M	$11.20M
Prepaid Expenses	$8.646M	$4.679M
Receivables	$43.08M	$40.83M	$36.54M
Other Receivables	$704.0K	$756.0K	$625.0K
Total Short-Term Assets	$134.2M	$136.0M	$141.9M
YoY Change	-9.64%	-4.13%	-17.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.26M	$11.64M	$12.76M
YoY Change	-18.79%	-8.74%	24.38%
Goodwill	$19.98M	$19.98M	$19.98M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$5.852M	$4.992M	$5.620M
YoY Change	8.71%	-11.17%	-21.6%
Long-Term Investments
YoY Change
Other Assets	$148.0K	$150.0K	$270.0K
YoY Change	-20.43%	-44.44%	-35.71%
Total Long-Term Assets	$37.23M	$36.76M	$38.62M
YoY Change	-5.52%	-4.82%	-7.72%
TOTAL ASSETS
Total Short-Term Assets	$134.2M	$136.0M	$141.9M
Total Long-Term Assets	$37.23M	$36.76M	$38.62M
Total Assets	$171.4M	$172.8M	$180.5M
YoY Change	-8.78%	-4.28%	-15.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.847M	$8.820M	$6.881M
YoY Change	19.8%	28.18%	-23.96%
Accrued Expenses	$11.02M	$10.99M	$13.69M
YoY Change	12.35%	-19.76%	-51.73%
Deferred Revenue			$496.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$43.56M	$45.86M	$41.75M
YoY Change	2.83%	9.85%	-27.14%
LONG-TERM LIABILITIES
Long-Term Debt	$48.59M	$48.48M	$48.02M
YoY Change	0.97%	0.96%	0.81%
Other Long-Term Liabilities	$4.773M	$5.491M	$4.076M
YoY Change	-1.97%	34.72%	-7.82%
Total Long-Term Liabilities	$53.37M	$53.97M	$52.09M
YoY Change	0.7%	3.6%	0.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.56M	$45.86M	$41.75M
Total Long-Term Liabilities	$53.37M	$53.97M	$52.09M
Total Liabilities	$96.92M	$99.82M	$93.84M
YoY Change	1.65%	6.38%	-14.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$191.9M	-$191.5M	-$163.9M
YoY Change	18.67%	16.82%	21.57%
Common Stock	$114.0K	$114.0K	$113.0K
YoY Change	0.88%	0.88%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$4.000M
YoY Change			-62.68%
Treasury Stock Shares			777.0K shares
Shareholders Equity	-$17.99M	-$19.52M	-$5.808M
YoY Change
Total Liabilities & Shareholders Equity	$171.4M	$172.8M	$180.5M
YoY Change	-8.78%	-4.28%	-15.38%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$2.110M	-$8.426M	-$2.339M
YoY Change	-195.26%	260.24%	-87.95%
Depreciation, Depletion And Amortization	$978.0K	$831.0K	$923.0K
YoY Change	-14.66%	-9.97%	-41.06%
Cash From Operating Activities	-$5.624M	$959.0K	$6.330M
YoY Change	74.01%	-84.85%	-237.01%
INVESTING ACTIVITIES
Capital Expenditures	$1.709M	-$374.0K	-$610.0K
YoY Change	-644.27%	-38.69%	-14.08%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$30.00K
YoY Change		-100.0%
Cash From Investing Activities	-$1.709M	-$374.0K	-$580.0K
YoY Change	444.27%	-35.52%	-18.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	66.00K	130.0K	-150.0K
YoY Change	200.0%	-186.67%	-100.22%
NET CHANGE
Cash From Operating Activities	-5.624M	959.0K	6.330M
Cash From Investing Activities	-1.709M	-374.0K	-580.0K
Cash From Financing Activities	66.00K	130.0K	-150.0K
Net Change In Cash	-7.267M	715.0K	5.600M
YoY Change	106.21%	-87.23%	-90.88%
FREE CASH FLOW
Cash From Operating Activities	-$5.624M	$959.0K	$6.330M
Capital Expenditures	$1.709M	-$374.0K	-$610.0K
Free Cash Flow	-$7.333M	$1.333M	$6.940M
YoY Change	151.3%	-80.79%	-277.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001376339
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Local Phone Number LocalPhoneNumber	651-9100
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	segment
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35887
	dei	Entity Registrant Name EntityRegistrantName	MIMEDX GROUP, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2792552
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1775 West Oak Commons Ct NE
	dei	Entity Address City Or Town EntityAddressCityOrTown	Marietta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30062
	dei	City Area Code CityAreaCode	770
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	MDXG
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	113668179	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73217000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87083000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40830000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40353000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	13976000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	11389000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4679000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6146000	usd
CY2022Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	756000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	743000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2582000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2809000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	136040000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	148523000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	7912000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	9165000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3728000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4696000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	19976000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	19976000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4992000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5383000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	150000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	186000	usd
CY2022Q3	us-gaap	Assets Assets	172798000	usd
CY2021Q4	us-gaap	Assets Assets	187929000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8820000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7385000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	24090000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23595000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10986000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9812000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1962000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1565000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	45858000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42357000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	48475000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	48127000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5491000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4869000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	99824000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	95353000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	100000	shares
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	100000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	100000	shares
CY2022Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	100000	shares
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	92494000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	92494000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	187500000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	187500000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113670017	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113668179	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112703926	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	111925216	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	114000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	113000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	171865000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	165695000	usd
CY2022Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1838	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	778710	shares
CY2022Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	7000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	4017000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191492000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161709000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-19520000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	82000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	172798000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	187929000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67689000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63074000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	193466000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191206000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12188000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10129000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33947000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32530000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	55501000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	52945000	usd
	us-gaap	Gross Profit GrossProfit	159519000	usd
	us-gaap	Gross Profit GrossProfit	158676000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	53475000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46289000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	158838000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	145291000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5953000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4368000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17429000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12770000	usd
CY2022Q3	mdxg	Investigation Restatement And Related InvestigationRestatementAndRelated	3001000	usd
CY2021Q3	mdxg	Investigation Restatement And Related InvestigationRestatementAndRelated	3170000	usd
	mdxg	Investigation Restatement And Related InvestigationRestatementAndRelated	8771000	usd
	mdxg	Investigation Restatement And Related InvestigationRestatementAndRelated	8304000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	175000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	193000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	519000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	647000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7103000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1075000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26038000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8336000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1270000	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-963000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3566000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3806000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8373000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2038000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29605000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12145000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	301000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	178000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	355000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8426000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2339000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-29783000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12500000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10096000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10096000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3913000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3913000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34667000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17039000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113448251	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110717073	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112650713	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110136517	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	113448251	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110717073	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112650713	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110136517	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-13603000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2372000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	137000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8426000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-19520000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-7137000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3811000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	45000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	188000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2339000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-5808000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	82000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10798000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	574000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1191000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-29783000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-19520000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-150000	usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	926000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11115000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1404000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4751000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12500000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	0	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-5808000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-29783000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12500000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10798000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11115000	usd
	us-gaap	Depreciation Depreciation	2549000	usd
	us-gaap	Depreciation Depreciation	3390000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2817000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	519000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	647000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	348000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	943000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	931000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	724000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	69000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	57000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	17000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-236000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3295000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1113000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2586000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	835000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1467000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3527000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	13000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-9420000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	287000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1990000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1090000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-828000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	495000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2085000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1724000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-16768000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	905000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-840000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12269000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1250000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	847000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2893000	usd
	mdxg	Payments For Application Costs Patent PaymentsForApplicationCostsPatent	128000	usd
	mdxg	Payments For Application Costs Patent PaymentsForApplicationCostsPatent	263000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	75000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	24000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-951000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3081000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1191000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4751000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	574000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1404000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	29000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	27000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-646000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3374000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13866000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5205000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	87083000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95812000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73217000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90607000	usd
CY2022Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q3	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	segment
CY2021Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, estimates related to the Company’s assessment of goodwill impairment, the measurement of right of use assets and lease liabilities, management’s assessment of the Company’s ability to continue as a going concern, estimates of fair value of share-based payments, estimate for allowance for doubtful accounts, estimates of sales returns and allowances, and valuation of deferred tax assets.</span></div>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	44660000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	41540000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3830000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1187000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40830000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40353000	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	400000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2800000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	670000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	364000	usd
CY2022Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7604000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6112000	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5702000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4913000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	13976000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	11389000	usd
CY2021Q3	us-gaap	Inventory Write Down InventoryWriteDown	500000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	700000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	189000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	189000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	43043000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	42043000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	35131000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	32878000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	7912000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	9165000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	698000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	831000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	923000	usd
	us-gaap	Depreciation Depreciation	2549000	usd
	us-gaap	Depreciation Depreciation	3390000	usd
CY2022Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	segment
CY2022Q3	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	segment
CY2021Q4	us-gaap	Goodwill Goodwill	20000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	303000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	148000	usd
CY2022Q3	mdxg	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	861000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2882000	usd
CY2022Q3	mdxg	Accrued Travel AccruedTravel	402000	usd
CY2022Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11920000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4992000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11791000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5383000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	175000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	193000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	519000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	647000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	174000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	698000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4185000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2806000	usd
CY2022Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2238000	usd
CY2021Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	2630000	usd
CY2022Q3	mdxg	Accrued Rebates AccruedRebates	878000	usd
CY2021Q4	mdxg	Accrued Rebates AccruedRebates	1343000	usd
CY2022Q3	mdxg	Accrued Administrative Fees Current AccruedAdministrativeFeesCurrent	616000	usd
CY2021Q4	mdxg	Accrued Administrative Fees Current AccruedAdministrativeFeesCurrent	559000	usd
CY2022Q3	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	999000	usd
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	788000	usd
CY2021Q4	mdxg	Accrued Travel AccruedTravel	385000	usd
CY2022Q3	mdxg	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	214000	usd
CY2021Q4	mdxg	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	694000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1454000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	607000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10986000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9812000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	50000000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2022Q3	mdxg	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	50000000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8426000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2339000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-29783000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12500000	usd
CY2022Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1670000	usd
CY2021Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1574000	usd
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4884000	usd
CY2022Q3	mdxg	Number Of Products NumberOfProducts	2	product
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	3613000	usd
CY2022Q3	mdxg	Temporary Equity Accretion Of Increasing Rate Dividend Feature TemporaryEquityAccretionOfIncreasingRateDividendFeature	0	usd
CY2021Q3	mdxg	Temporary Equity Accretion Of Increasing Rate Dividend Feature TemporaryEquityAccretionOfIncreasingRateDividendFeature	0	usd
	mdxg	Temporary Equity Accretion Of Increasing Rate Dividend Feature TemporaryEquityAccretionOfIncreasingRateDividendFeature	0	usd
	mdxg	Temporary Equity Accretion Of Increasing Rate Dividend Feature TemporaryEquityAccretionOfIncreasingRateDividendFeature	926000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1670000	usd
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1574000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4884000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4539000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10096000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3913000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34667000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17039000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113448251	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110717073	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112650713	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110136517	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10096000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3913000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34667000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17039000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1670000	usd
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1574000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4884000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	4539000	usd
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	700000	usd
CY2022Q3	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	-1670000	usd
CY2021Q3	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	-1574000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	-4884000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	-4539000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10096000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3913000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34667000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17039000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113448251	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110717073	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112650713	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110136517	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	29269481	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	30658193	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28858049	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	30185813	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29269481	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30658193	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28858049	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30185813	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	113448251	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110717073	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	112650713	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110136517	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29269481	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30658193	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28858049	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30185813	shares
CY2020Q3	mdxg	Temporary Equity Conversion Price Per Share TemporaryEquityConversionPricePerShare	5.25
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	700000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1050344	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.14
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y25D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1444845	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	285001	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.01
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	109500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.00
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1050344	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.14
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y25D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	700000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.006
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.148
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.006
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.029
	us-gaap	Interest Paid Net InterestPaidNet	3233000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3269000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	184000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	157000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	353000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	mdxg	Temporary Equity Deemed Dividends TemporaryEquityDeemedDividends	0	usd
	mdxg	Temporary Equity Deemed Dividends TemporaryEquityDeemedDividends	926000	usd
	mdxg	Fair Value Of Non Cash Consideration Received For Option Exercise FairValueOfNonCashConsiderationReceivedForOptionExercise	0	usd
	mdxg	Fair Value Of Non Cash Consideration Received For Option Exercise FairValueOfNonCashConsiderationReceivedForOptionExercise	380000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	189000	usd
	mdxg	Notes Receivable For Sale Of Property And Equipment NotesReceivableForSaleOfPropertyAndEquipment	0	usd
	mdxg	Notes Receivable For Sale Of Property And Equipment NotesReceivableForSaleOfPropertyAndEquipment	75000	usd
CY2019Q1	mdxg	Contingency Loss Number Of Securities Class Actions ContingencyLossNumberOfSecuritiesClassActions	2	class_action
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67689000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63074000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	193466000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191206000	usd
CY2022Q3	mdxg	Revenue From Contract With Customer Number Of Distribution Channels RevenueFromContractWithCustomerNumberOfDistributionChannels	2	distribution_channel
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67689000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63074000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	193466000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191206000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67689000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12188000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	53475000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5953000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	175000	usd
CY2022Q3	mdxg	Investigation Restatement And Related InvestigationRestatementAndRelated	3001000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7103000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	831000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2372000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63074000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10129000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46289000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4368000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	193000	usd
CY2021Q3	mdxg	Investigation Restatement And Related InvestigationRestatementAndRelated	3170000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1075000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	923000	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	3811000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	193466000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33947000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	158838000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17429000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	519000	usd
	mdxg	Investigation Restatement And Related InvestigationRestatementAndRelated	8771000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26038000	usd
	us-gaap	Depreciation Depreciation	2549000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10798000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191206000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32530000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	145291000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12770000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	647000	usd
	mdxg	Investigation Restatement And Related InvestigationRestatementAndRelated	8304000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8336000	usd
	us-gaap	Depreciation Depreciation	3390000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11115000	usd

Files In Submission

Name	View Source	Status
0001376339-22-000127-index-headers.html	Edgar Link	pending
0001376339-22-000127-index.html	Edgar Link	pending
0001376339-22-000127.txt	Edgar Link	pending
0001376339-22-000127-xbrl.zip	Edgar Link	pending
a20220930-10qex311final.htm	Edgar Link	pending
a20220930-10qex312final.htm	Edgar Link	pending
a20220930-10qex321final.htm	Edgar Link	pending
a20220930-10qex322final.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mdxg-20220930.htm	Edgar Link	pending
mdxg-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mdxg-20220930_cal.xml	Edgar Link	unprocessable
mdxg-20220930_pre.xml	Edgar Link	unprocessable
mdxg-20220930_lab.xml	Edgar Link	unprocessable
mdxg-20220930_def.xml	Edgar Link	unprocessable
mdxg-20220930_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDXG
MIMEDX GROUP, INC. Stock $mdxg

2022 Q4 Form 10-Q Financial Statement

#000137633922000127 Filed on November 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG MIMEDX GROUP, INC. Stock $mdxg

2022 Q4 Form 10-Q Financial Statement

#000137633922000127 Filed on November 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG
MIMEDX GROUP, INC. Stock $mdxg